Skip to main content

Table 3 Pooled sensitivities, specificities, and AUCs for MRI-inclusive and clinical nomograms for predicting EPE (validation cohorts only)

From: Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis

Nomogram

No. of cohorts

No. of patients

Sensitivity (95% CI)

Heterogeneity

Specificity (95% CI)

Heterogeneity

AUC (95% CI)

I 2 (%)

Cochran

Q p value

I2 (%)

Cochran

Q p value

MRI-inclusive nomograms

13

2177

0.76 (0.67, 0.83)

81.18 (71.69, 90.66)

 < 0.001

0.71 (0.59, 0.80)

94.75 (92.92, 96.58)

 < 0.001

0.80 (0.76, 0.83)

Clinical nomograms

11

2437

0.68 (0.59, 0.75)

84.21 (75.93, 92.49)

 < 0.001

0.71 (0.64, 0.78)

88.50 (82.98, 94.02)

 < 0.001

0.75 (0.71, 0.79)

Partin table

8

2105

0.73 (0.62, 0.82)

88.29 (82.57, 95.01)

 < 0.001

0.60 (0.47, 0.72)

93.26 (89.97, 96.56)

 < 0.001

0.72 (0.68, 0.76)

MSKCCn

5

442

0.68 (0.60, 0.75)

26.26 (0, 94.20)

0.25

0.76 (0.70, 0.82)

28.18 (0, 95.54)

0.23

0.79 (0.75, 0.82)

  1. CI confidence interval, AUC area under the receiver operating characteristic curve, MSKCCn Memorial Sloan Kettering Cancer Center nomogram